News | December 28, 2008

Prostate Cancer Deaths Cut in Half with Aggressive Therapy

December 29, 2008 - A combination treatment of prostate cancer can cut death rates in half, according to results from a Scandinavian study published in the Dec. 16 online issue of The Lancet.

These positive results may help bring European oncologists in line with practice in the U.S., where such therapy has been used for many years. In the study, which involved 875 men, half were treated with a combination of radiation therapy and hormone-deprivation therapy and the other half received hormone therapy alone. At the end of 8 years of follow-up, 79 men had died in the hormone therapy group, but only 37 men had died in the combination therapy group. The men receiving combination therapy group did, however, have higher rates of fatigue, insomnia and sexual problems. Nonetheless, the investigators concluded that men with prostate cancer do benefit from aggressive therapy.

In Europe, many doctors have shied away from using combination therapy, considering it too harsh for the patients. One of the study authors asserted that it is not enough to treat patients with hormone therapy but that radiation therapy must be added in order to see a dramatic increase in survival. He recommended that this combination should become the new standard of treatment.

Source: Oncology Stat

For more information: www.thelancet.com and www.oncologystat.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Lung Decision Precision
News | Lung Cancer | June 04, 2018
For smokers and former smokers, the threat of lung cancer always lurks in the shadows.
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
Overlay Init